Publication Date
| In 2026 | 0 |
| Since 2025 | 0 |
| Since 2022 (last 5 years) | 0 |
| Since 2017 (last 10 years) | 0 |
| Since 2007 (last 20 years) | 1 |
Descriptor
| Autism | 3 |
| Drug Therapy | 3 |
| Functional Behavioral… | 3 |
| Behavior Disorders | 2 |
| Behavior Modification | 2 |
| Adult Education | 1 |
| Aggression | 1 |
| Antisocial Behavior | 1 |
| Children | 1 |
| Clinical Diagnosis | 1 |
| Communication Skills | 1 |
| More ▼ | |
Source
| Journal of Autism and… | 3 |
Author
Publication Type
| Journal Articles | 3 |
| Reports - Research | 3 |
Education Level
Audience
Location
| Japan | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Direct linkPost, Michal; Haymes, Linda; Storey, Keith; Loughrey, Tamara; Campbell, Camille – Journal of Autism and Developmental Disorders, 2014
Stalking behavior among some students with Autism Spectrum Disorders (ASDs) is of concern both for the individual being stalked as well as the student with ASDs. This manuscript reviews effective interventions based upon functional assessment and appropriate positive behavior supports. Specific interventions for addressing staking behavior by…
Descriptors: Autism, Pervasive Developmental Disorders, Antisocial Behavior, Behavior Disorders
Sugie, Yoko; Sugie, Hideo; Fukuda,Tokiko; Ito, Masataka; Sasada, Yumiko; Nakabayashi, Mutsumi; Fukashiro, Kazunobu; Ohzeki, Takehiko – Journal of Autism and Developmental Disorders, 2005
We studied the correlation between response to fluvoxamine and serotonin transporter gene promoter region polymorphism (5-HTTLPR). Eighteen children with autistic disorder completed a 12-week double-blind, placebo-controlled, randomized crossover study of fluvoxamine. Behavioral assessments were obtained before and at 12 weeks of treatment.…
Descriptors: Autism, Correlation, Genetics, Children
Peer reviewedCrosland, Kimberly A.; Zarcone, Jennifer R.; Lindauer, Steven E.; Valdovinos, Maria G.; Zarcone, Troy J.; Hellings, Jessica A.; Schroeder, Stephen R. – Journal of Autism and Developmental Disorders, 2003
The atypical antipsychotic medication risperidone was evaluated using a double-blind, placebo-controlled design to treat destructive behavior in two males (ages 6 and 24) with autism. Destructive behavior during the demand condition was significantly reduced during the medication phases, whereas it continued to occur to obtain tangible items and…
Descriptors: Adult Education, Aggression, Autism, Behavior Disorders
